BioSpace News Archive

Deals

Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ

Asensus Surgical, Inc. today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc.

June 7, 2024
·
7 min read
Genetown

Combined General Meeting of June 24, 2024

Biophytis SA will hold its Combined General Meeting on June 24, 2024 at 2pm at Sorbonne Université - Amphi Herpin - 4 Place Jussieu, 75005 Paris.

June 7, 2024
·
3 min read
Business

Solarvest Elects New Board of Directors

Solarvest BioEnergy Inc. (TSXV: SVS.H) (“Solarvest”, or the “Company”), an algal biologic company specializing in organic ingredient production

June 7, 2024
·
4 min read
Biotech Bay

Kyverna Therapeutics to Present Data on 50 Patient Experience at Symposium at EULAR 2024

Kyverna Therapeutics, Inc. announced today that it will host a sponsored symposium to present the largest and most diverse set of data to date from a cohort of 50 patients treated with the CAR in KYV-101, an autologous, fully human anti-CD19 CAR T-cell immunotherapy.

June 7, 2024
·
5 min read
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

NeurAxis, Inc. today announced a submission to the FDA for expansion of its IB-Stim label. The new submission is significant as it would allow access to a larger patient population beyond 11-18 years of age and allow for marketing of 4 devices per prescription.

June 7, 2024
·
5 min read
Potential Add-on Treatment for Patients with Parkinson’s Disease: Stimvia Completes Pilot Study and Announces Promising Initial Results

Stimvia, a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on Parkinson’s Disease and is expecting promising results.

June 7, 2024
·
2 min read
Biotech Bay

Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders

Helix , the leading population genomics company, is launching new clinico-genomic datasets to enable life science companies to drive precision medicine drug discovery and development.

June 7, 2024
·
2 min read
Genetown

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2024-2025 formula, targeting the SARS-CoV-2 variant JN.1.

June 7, 2024
·
5 min read
Business

Calyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents

Calyx / Invicro, a global leader in providing medical imaging solutions and development services to the clinical research community, announces a strategic partnership with BAMF Health, a world leader in molecular imaging and theranostics.

June 7, 2024
·
3 min read
BioMidwest

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024

NewAmsterdam Pharma Company N.V. announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 90,000 of NewAmsterdam’s ordinary shares to five non-executive new hires.

June 7, 2024
·
2 min read